Oracles, Billion

Oracle's $40 Billion Question: Can Big AI Bets Outrun a Balance Sheet Under Siege?

Published on 08/15/2026 at 03:03 | Redaktion boerse-global.de

Oracle shares slide on $40B fiscal 2027 capital needs and Michael Burry's expanded short, despite strong cloud growth guidance.

Oracle Stock Drops 4% on $40B Capital Plan, Burry Short Bet
Oracle's $40 Billion Question: Can Big AI Bets Outrun a Balance Sheet Under Siege? Illustration mit AI erstellt übermittelt durch boerse-global.de

The market's verdict on Oracle arrived in two sharp jabs on Friday. Shares slid 4.1 percent to close at €129.90, pressured by the disclosure of a $40 billion capital requirement for fiscal 2027 — including a $20 billion equity program — and by news that famed investor Michael Burry had expanded his bearish wager against the software giant.

Burry, the investor immortalized in "The Big Short," added to his short position at a price of $152, having first disclosed a bearish stance on August 7 at $144.63. His thesis centers on a looming glut of AI computing capacity by 2028, compounded by Oracle's heavy debt load and off-balance-sheet commitments.

The stock now sits roughly 56 percent below its 52-week high of €294.85, reached last September. Yet the technical picture tells a more nuanced story: the shares are just 0.6 percent from their 50-day moving average of €130.74, suggesting near-term stabilization, while trailing the 200-day average of €150.38 by about 14 percent.

The Capital Conundrum

Oracle's financing needs land at a delicate moment. The company reported negative free cash flow of $23.7 billion for fiscal 2026, with total liabilities swelling to $218.7 billion. Capital expenditures hit $55.7 billion for the year — a 162 percent surge — as the company races to build out AI-ready data centers that consume vast sums long before revenue materializes.

The strain has not gone unnoticed by rating agencies. S&P Global Ratings downgraded Oracle to BBB- in July, one notch above junk status, while Moody's maintains a negative outlook. The stock has recovered 3.6 percent since that downgrade, but Friday's capital announcement has reignited the fundamental question: can Oracle convert its promised cloud growth into cash flow quickly enough to justify the borrowing?

Should investors sell immediately? Or is it worth buying Oracle?

Management's own projections are ambitious. For fiscal 2027, the company guides to $90 billion in revenue, a 34 percent increase on a constant-currency basis, with cloud growth of 58 to 64 percent expected in the first quarter. Non-GAAP earnings per share are projected to rise 17 to 20 percent.

Cost-Cutting in Tandem

Adding to the narrative of a company straining to balance growth and discipline, Oracle is simultaneously trimming its workforce. Media reports indicate another round of layoffs is planned for August, with some teams facing cuts in the double-digit percentage range, ahead of the second fiscal quarter beginning September 1.

The company had already reduced headcount by 21,000 positions — roughly 13 percent — to about 141,000 employees during the past fiscal year as part of a restructuring plan that carried $1.8 billion in special charges.

Insider activity has done little to calm nerves. Over the past three months, company insiders sold $63.7 million worth of shares, with no purchases recorded.

The Bull Case: Momentum and Backlog

Optimists point to operational momentum that remains formidable. In the fourth quarter of fiscal 2026, total revenue climbed 21 percent to $19.2 billion, while cloud revenue jumped 47 percent to $9.9 billion. The company has also reported a 93 percent surge in cloud segment revenue for the quarter, underscoring the strength of demand.

Strategic alliances have piled up recently. An expanded partnership with Amazon Web Services will make "Oracle AI Database@AWS" available across 22 AWS regions. A multi-year collaboration with Quantinuum aims to integrate Helios quantum computing into Oracle Cloud Infrastructure. A $400 million HR modernization contract with CACI and the expansion of Oracle Health into Ontario hospitals have contributed to a 17.5 percent share price gain over the past two weeks.

The company also secured a significant defense contract in early August: a five-year Pentagon deal for enterprise software with a potential value of up to $7 billion.

Perhaps most importantly, Oracle's remaining performance obligations — the backlog of committed future revenue — stand at a hefty $638 billion, providing a substantial cushion of contracted business.

Oracle at a turning point? This analysis reveals what investors need to know now.

The Bear Case: Leverage and Skepticism

UBS analysts trimmed their price target on August 3 to $245 from $285, maintaining a "Buy" rating but explicitly flagging risks tied to rising AI infrastructure spending and uncertain returns on invested capital.

The bearish scenario is straightforward: a $40 billion capital program arriving while free cash flow is deeply negative increases dependence on capital markets. Should interest rates move adversely or AI infrastructure demand soften, the debt burden would weigh more heavily — potentially triggering another downgrade into speculative territory.

Burry's warnings about overcapacity in AI compute by 2028 echo a broader market skepticism toward the massive capital outlays of tech giants. The parallel cost-cutting measures suggest Oracle itself is trying to contain expenses, a balancing act that could read as a warning sign if execution falters.

What to Watch

The immediate test comes with the quarterly report expected on September 8, 2026, which should reveal whether the multibillion-dollar capital raise is already translating into operational results. For now, the stock's proximity to its 50-day average suggests much of the near-term pessimism may be priced in. But with a legendary bear circling and a balance sheet stretched thin, Oracle's ability to deliver on its aggressive growth targets will determine whether this is a calculated bet on the future or a gamble that has gone too far.

Ad

Oracle Stock: New Analysis - 15 August

Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Oracle analysis...

Disclaimer...

en | US68389X1054 | ORACLES | boerse | 69951469 |